| The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR. | None |
| The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. | None |
| Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression. | None |
| [Specific cleavage of the Ha-ras oncogene with topoisomerase I]. | None |
| Analysis of the methylation pattern of c-Ha-ras oncogene in human prostatic cancer. | None |
| Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. | None |
| Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene. | None |
| Disordered metabolism of microfilament proteins, tropomyosin and actin, in mouse mammary epithelial cells expressing the Ha-ras oncogene. | None |
| Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. | None |
| Activation of c-Ha-ras proto-oncogene by in vitro chemical modification with 2-amino-6-methyldipyrido[1,2-a:3 ,2 -d]imidazole (Glu-P-1) and 4-nitroquinoline N-oxide (4NQO). | None |
| Transforming activity of human c-Ha-ras-1 proto-oncogene generated by the binding of 2-amino-6-methyl-dipyrido[1,2-a:3 ,2 -d]imidazole and 4-nitroquinoline N-oxide: direct evidence of cellular transformation by chemically modified DNA. | None |
| Interaction of the human insulin receptor with the ras oncogene product p21. | None |
| A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. | None |
| The three-dimensional structure of c-H-ras p21: implications for oncogene and G protein studies. | None |
| Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats. | None |
| Proton NMR studies of the GDP.Mg2+ complex of the Ha-ras oncogene product p21. | None |
| Inhibition of c-H-ras oncogene induced transformation of rat embryo fibroblasts by cotransfected polynucleotides containing alternating purine-pyrimidine sequences. | None |
| Effects of benzamidine derivatives on Ha-ras-1 mRNA accumulation in a Chinese hamster cell line transformed with the activated human T24 Ha-ras-1 oncogene. | None |
| Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene. | None |
| Crystallization of human c-H-ras oncogene products. | None |